News
Easter Closure for PBS Approved Supplier Applications
2026 Easter shutdown period for key deadlines for PBS approved supplier applications.
Modernising medication management in residential aged care - eNRMC update
All ten eNRMC software vendors have successfully passed electronic prescribing conformance assessment, representing a major milestone in modernising medication management across residential aged care.
Updates to PBS Approved Suppliers forms – March 2026
Updated application and notification forms now available on the PBS Approved Suppliers Guides and Forms page.
PBS prescription medicines more affordable for Australians
The Australian Government has launched a new advertising campaign to raise awareness about changes to maximum patient costs for Pharmaceutical Benefits Scheme (PBS) medicines that help ease the cost of medicines.
Electronic National Residential Medication Charts (eNRMC) – Further Extension to timeframes for electronic prescribing
Electronic National Residential Medication Charts (eNRMC) – Further Extension to timeframes for electronic prescribing.
Australian Community Pharmacy Authority (ACPA) meeting dates for 2026
The meeting dates and associated application lodgement dates for 2026 ACPA meetings are now available.
Changes to the Minister’s discretionary power to approve supply of PBS medicines
A change to legislation has reduced the mandatory timeframe in which the Minister must decide whether to approve a request to supply PBS medicines.
Have your say on the GST status of pain relief medicine
We’re reviewing the GST-free status of small packs of common pain relief, such as aspirin, ibuprofen and paracetamol. You can now have your say until 8 September 2025.
Registrations now open for the National Medicines Symposium 2025
The Australian Commission on Safety and Quality in Health Care has opened registrations for the National Medicines Symposium 2025.
Community Service Obligation continues to deliver
New CSO Deeds have been finalised with Distributors to ensure access to PBS Medicines continues.
Improving health literacy and educating health professionals about safer medicine use
$37.5 million investment to improve consumer health literacy and support health professional education to promote the safe and effective use of medicines.
The handbook of tools to support medicine management in multimorbidity and polypharmacy is now available
We commissioned the University of South Australia to develop a handbook of tools to support medicine management in multimorbidity and polypharmacy.
Australians benefit from freeze to maximum cost of PBS medicines
The Australian Government has launched an advertising campaign to raise awareness about a freeze on the maximum patient cost of PBS medicines, a key measure to help ease the cost of medicines.
Registrations now open for the National Medicines Symposium 2024
The Australian Commission on Safety and Quality in Health Care has opened registrations for the National Medicines Symposium 2024.
The Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program – Grant opportunities now open
Applications are now open for the QUDTP grant opportunities for the Health Professional Education and Consumer Health Literacy streams.
Consumer Health Literacy and Health Professional Education Grant Opportunity Forum presentation
Learn about the forum we hosted for stakeholders interested in the Consumer Health Literacy or Health Professional Education Grant Opportunity.
Stakeholder Forum – Health Professional Education and Consumer Health Literacy
We are hosting a Quality Use of Diagnostics, Therapeutics and Pathology (QUDTP) Program Stakeholder Forum on 22 April 2024. The forum will discuss 2 grant opportunities for Health Professional Education and Consumer Health Literacy. Register your interest today.
More medicines available for 60-day prescriptions
On 1 March 2024 the range of Pharmaceutical Benefits Scheme (PBS) medicines available for 60-day prescriptions expanded. This will give more Australians twice the medication on a single prescription.
New Australian Clinical Trials website
We have upgraded and refreshed the Australian Clinical Trials website. Learn more about the new site.
Medicines just got cheaper
Selected Pharmaceutical Benefits Scheme (PBS) medicines can now be prescribed for a 60-days for the price of a single prescription. This means many Australians who have a stable, ongoing health condition can now save money on their regular medication.
Lower medicine costs for chronic health conditions
Under the first stage of the 60-day dispensing policy, eligible Australians living with chronic health conditions will have access to 92 cheaper Pharmaceutical Benefits Scheme (PBS) medicines.
More medicine, for less
The Australian Government is making hundreds of medicines cheaper by allowing millions of Australians to buy two months’ worth of medicine for the price of a single prescription.
Statement on 60-day medicine dispensing
A statement from Australia's acting Chief Medical Officer, Professor Michael Kidd, responding to reports in the media about 60-day medicine dispensing.
Save more on Pharmaceutical Benefits Scheme (PBS) medicines
From 1 January 2023, the maximum price of most PBS medicines for non-concessional patients was reduced from $42.50 to $30. Don’t delay buying your PBS Medicines.
Therapeutic Goods Administration Adj. Professor John Skerritt's interview on ABC Radio National on 9 January 2023
Read the transcript of Therapeutic Goods Administration Adjunct Professor John Skerritt's interview with Hamish Macdonald on ABC Radio National on 9 January 2023.
Date last updated: